Impedimed Limited · ASX:IPD

Impedimed — Bioshares Biotech Summit 2016

30 slides from Impedimed's conference presentation, Jul 29, 2016

  1. Slide 1: ImpediMed to present at Bioshares Biotech Summit 2016

    29 July 2016 For personal use only ASX ANNOUNCEMENT IMPEDIMED TO PRESENT AT BIOSHARES BIOTECH SUMMIT 2016 Brisbane, Australia and Carlsbad, Calif. - ImpediMed Limited (ASX: IPD) a global provider of medical technology to measure, monitor and manage fluid status and body composition, today announced

  2. Slide 2: About ImpediMed

    About ImpediMed Founded and headquartered in Brisbane, Australia with U.S. offices in Carlsbad, Calif. and Bloomington, Minn., ImpediMed is the world leader in the development and distribution of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the non- invasive clin

  3. Slide 3: Corporate Overview

    For personal use only 1 Impedimed is the leading developer and manufacturer of fluid measurement and body composition technology. Our products use a technology called Bioimpedance Spectroscopy (BIS), which uses over 256 unique frequencies to accurately assess both intra and extracellular fluid withi

  4. Slide 4: Disclaimer

    2 Disclaimer For personal use only • The material contained in this document is a presentation of general information about the activities of ImpediMed Limited (“ImpediMed”) current as at the date of this presentation. The information is provided in a summary form, does not purport to be complete an

  5. Slide 5: Forward Looking Statements

    3 Forward Looking Statements For personal use only • Certain statements in this presentation may constitute forward-looking statements or statements about future matters that are based on management’s current expectations and beliefs. The forward-looking statements in this release include statements

  6. Slide 6: Opportunities for Digital Health Solutions

    4 Opportunities for Digital Health Solutions For personal use only Session Topic Description The Growth Challenge – Opportunities for Digital Health Solutions In this session which will focus on the rapidly emerging opportunities for products/services offering digital health technology solutions, th

  7. Slide 7: Digital Health

    5 Digital Health For personal use only The broad scope of digital health includes categories such as mobile health (mHealth), health information technology (IT), wearable devices, telehealth and telemedicine, and personalised medicine. Providers and other stakeholders are using digital health in the

  8. Slide 8: US Healthcare Spending is Reaching a Tipping Point

    6 US Healthcare Spending is Reaching a Tipping Point For personal use only Total National Health Expenditures 1960-2014 Projected National Healthcare Expenditures (Aggregate Spending, US $ Billions, Adjusted for Inflation) 2015 - 2025 $3,100 Health spending is projected to grow 1.3 percentage points

  9. Slide 9: An Aging Population

    7 An Aging Population For personal use only The Prevalence of Chronic Disease Increases with Age US Population 65+ by Age:1910-2050 80% 90,000,000 67,500,000 49% 45,000,000 22,500,000 18% 7% 0 0-17 18-44 45-64 65+ 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050 % of US Pop

  10. Slide 10: Chronic Disease

    8 Chronic Disease For personal use only % of Every Dollar of Spending Goes to Treating People with Multiple % of Healthcare Services Used by People with Multiple Chronic Conditions Chronic Conditions All Clinician Visits 64% 71% 93% 71% All Prescriptions 83% All Home Health Care Visits 88% All Inpat

  11. Slide 11: CMS is Aggressively Addressing Escalation Costs

    9 CMS is Aggressively Addressing Escalation Costs For personal use only Chronic Care Quality Measures Hospital Readmission Reduction Plan (HRRP) HRRP penalises hospitals with relatively higher readmission rates for Key CMS chronic care quality measurement programs includes Medicare patients. Physici

  12. Slide 12: Chronic Disease

    10 Chronic Disease For personal use only Top 10 Diagnoses Ranked by Average Aggregate Annual Expenditures 2012 Blue Shading Represents Chronic Disease Heart Conditions $100,996 Trauma-related Disorders $92,137 Cancer $87,538 Mental Disorders $83,598 COPD, Asthma $75,906 Osteoarthritis & non-traumati

  13. Slide 13: Heart Failure is a Major Burden on the US Healthcare System

    Heart Failure is a Major Burden on 11 the US Healthcare System For personal use only CHF is Among the Most Expensive Diseases for Medicare Heart Failure Hospitalisation • Estimated 5.7 million people in the US have heart failure. • 870,000 newly diagnosed cases per year. • Heart failure costs the US

  14. Slide 14: Controlling Chronic Disease Costs

    12 Controlling Chronic Disease Costs For personal use only Potential economic impact of Healthcare Internet of Things (IoT) offerings by vertical Total Savings Commercial Vertical Disease State Opportunity Opportunity Heart Disease, Remote Patient Monitoring COPD/Asthma, $200+ billion ~$15 billion D

  15. Slide 15: Key Players

    For personal use only Key Players 13

  16. Slide 16: Smartphone Usage in the US by Age - Early 2015

    14 Smartphone Usage in the US by Age - Early 2015 For personal use only 90% 85% 79% 68% 54% 45% 27% 23% 0% 8-29 30-49 50-64 65+

  17. Slide 17: Keys to Success

    15 Keys to Success For personal use only • Easy to Use • Clinically Meaningful • Integrated • Reduce Costs • Accurate • Risk Stratification • Evidence Based • Artificial Intelligence • Actionable Data • Ecosystem

  18. Slide 18: For personal use only

    For personal use only 16 Impedimed is the leading developer and manufacturer of fluid measurement and body composition technology. Our products use a technology called Bioimpedance Spectroscopy (BIS), which uses over 256 unique frequencies to accurately assess both intra and extracellular fluid with

  19. Slide 19: For personal use only

    17 “ For personal use only " A t r u l y d i s r u p t i v e t e c h n o l o g y n o t o n l y c h a n g e s t h e w a y t h a t p e o p l e t h i n k b u t a l s o t h e w a y t h e y r e a c t . " Copyright 2016 ImpediMed. All Rights Reserved

  20. Slide 20: Our challenge was clear

    18 WHOLE BODY ARTIFICIAL For personal use only BIS INTELLIGENCE Our challenge was clear. BEHAVIOR INTERNET OF MODIFICATION THINGS To create a device that would include the following… RISK REMOTE PATIENT STRATIFICATION MONITORING Copyright 2016 ImpediMed. Impedimed. All Rights Reserved

  21. Slide 21: Fluid Status, Body Composition, Hydration

    For personal use only 19 FLUID STATUS BODY COMPOSITION HYDRATION Copyright 2016 ImpediMed. All Rights Reserved

  22. Slide 22: For personal use only

    20 HEART HYPERTENSION ORTHOPEDICS COPD HIV/AIDS For personal use only FAILURE KIDNEY MEDICATION DISEASE COMPLEX CHRONIC MANAGEMENT DISEASE MANAGEMENT WOMEN’S DIABETES SENIOR CANCER OBESITY HEALTH CARE SURVIVORS Copyright 2016 ImpediMed. All Rights Reserved

  23. Slide 23: Say Hello to SOZO

    21 Say Hello to For personal use only The world’s most accurate technology for use in body composition, fluid status and hydration management combined with the technology of remote patient monitoring. Copyright 2016 Impedimed. All Rights Reserved

  24. Slide 24: Save, Heal, Create

    For personal use only SAVE SOZO’s BIS technology has been clinically proven to be the new “Gold Standard” for fluid status and body composition. SOZO’s meaning HEAL SOZO will work with patients who have and continue to overcome chronic diseases. Sozo is originally a Greek word that simply means “to

  25. Slide 25: Human-Centered Design

    For personal use only 23 HUMAN-CENTERED DESIGN Countless hours of human factors engineering and human-centered design to create the ultimate user centric device. SIMPLE YET ELEGANT PHYSICAL INTERFACE It should never take more than one step to give the user what they need. This philosophy of keeping

  26. Slide 26: Highlights

    24 Highlights For personal use only • 4 Channels • Device for clinic as well as in-home monitoring • Real-time monitoring • Direct Segmental – arms, legs and torso • Both sides and full body • Thorax region • Segmental body composition without empirical estimation • Hypertension / Hypotension • Maln

  27. Slide 27: Body of Evidence

    For personal use only 25 Body of Evidence Based on clinical research and involvement of leading healthcare institutions and professionals, BIS Today, chronic disease makes up technology has demonstrated value both the highest risk and highest and credibility. cost amongst patients in the Trending Da

  28. Slide 28: Our new product line

    For personal use only 26 Our new product line is divided into two main categories. Wellness & Health Copyright 2016 Impedimed. All Rights Reserved

  29. Slide 29: For personal use only

    For personal use only 27 Copyright 2016 Impedimed. All Rights Reserved

  30. Slide 30: For personal use only

    Copyright 2016 Impedimed. All Rights Reserved For personal use only 28 Copyright 2016 Impedimed. All Rights Reserved

ImpediMed — Bioshares Biotech Summit 2016 on 6ix